Adrian Covic
Adrian Covic is an expert in Nephrology at Spitalul Clinic Dr. C. I. Parhon (Romania). As of October 2026, ScienceLeadR ranks Adrian Covic in the top 1% of experts worldwide for Kidney Transplantation, Renal Insufficiency and Hypertension. Adrian Covic has authored 791 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 2,443 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Transplantation - Urology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1991 - 2026
Number : 791
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Atrial Cardiomyopathy in Patients with Cardiovascular-Kidney-Metabolic Syndrome: Non-Invasive Characterization (ATRIO-CKM). PMID 42882351 — heart failure, diastolic, kidney, cardiology, prevalence, interatrial block, metabolic syndrome, cardiomyopathies | Diagnostics (Basel) | 2026 | 0 |
| Haemodiafiltration, haemofiltration and haemodialysis for adults with kidney failure. PMID 42867023 — quality of life, kidney, fatigue, morbidity, research, therapeutics | Cochrane Database Syst Rev | 2026 | 0 |
| Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty. PMID 42788969 — nephrology, renal dialysis, therapeutics, kidney transplantation | Nephrol Dial Transplant | 2026 | 0 |
| From Guidelines to Practice: Pilot Implementation and Analytical Boundaries of a Focused ADPKD-Spectrum Gene Panel. PMID 42739200 — research design, genes, pilots, pseudogenes, polycystic kidney, autosomal dominant | Diagnostics (Basel) | 2026 | 0 |
| Kidney outcomes and safety of sodium-glucose cotransporter-2 inhibitor therapy in autosomal dominant polycystic kidney disease: systematic review and meta-analysis. PMID 42586506 — diabetes mellitus, kidney diseases, sodium-glucose transport proteins, sodium-glucose transporter 2 inhibitors, safety, kidney, therapeutics, polycystic kidney diseases, polycystic kidney, autosomal dominant | Diabetes Res Clin Pract | 2026 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 8
LeadR Networks
Main global connection map